User profiles for K. Giacomini

Kathleen M. Giacomini

Professor, UCSF
Verified email at ucsf.edu
Cited by 31766

SLC transporters as therapeutic targets: emerging opportunities

L Lin, SW Yee, RB Kim, KM Giacomini - Nature reviews Drug discovery, 2015 - nature.com
Solute carrier (SLC) transporters — a family of more than 300 membrane-bound proteins that
facilitate the transport of a wide array of substrates across biological membranes — have …

Metformin pathways: pharmacokinetics and pharmacodynamics

L Gong, S Goswami, KM Giacomini… - Pharmacogenetics …, 2012 - journals.lww.com
… MATE1 and MATE2-K are expressed in the apical membrane of the renal proximal tubule
cells, and studies in healthy individuals suggest that they contribute to the renal excretion of …

The concentrative nucleoside transporter family, SLC28

JH Gray, RP Owen, KM Giacomini - Pflügers Archiv, 2004 - Springer
The SLC28 family consists of three subtypes of sodium-dependent, concentrative nucleoside
transporters, CNT1, CNT2, and CNT3 (SLC28A1, SLC28A2, and SLC28A3, respectively), …

[HTML][HTML] Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

…, EG Burchard, CM Brett, KM Giacomini - The Journal of …, 2007 - Am Soc Clin Investig
… To obtain the K m and V max in the kinetic studies, the data were fit to the Michaelis-Menten
equation: V = V max × S/(K m +S), where V max is the maximum transport rate, K m is the …

Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics

…, EG Burchard, CM Brett, KM Giacomini - Clinical …, 2008 - Wiley Online Library
The goal of this study was to determine the effects of genetic variation in the organic cation
transporter 1, OCT1, on the pharmacokinetics of the antidiabetic drug, metformin. Twenty …

Organic cation transporters are determinants of oxaliplatin cytotoxicity

…, JW Gray, X Chen, SJ Lippard, KM Giacomini - Cancer research, 2006 - AACR
Although the platinum-based anticancer drugs cisplatin, carboplatin, and oxaliplatin have
similar DNA-binding properties, only oxaliplatin is active against colorectal tumors. The …

Cloning and functional expression of a human liver organic cation transporter

…, AT Gray, SC Yost, S Terashita, KM Giacomini - Molecular …, 1997 - ASPET
… in the specified Na + and K + buffer were measured with the use of standard microelectrode
techniques (16). In the pH-dependency studies, the K + buffers were used at various pH …

The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin‐Associated Musculoskeletal …

…, A Gaedigk, KM Giacomini, KE Caudle… - Clinical …, 2022 - Wiley Online Library
Statins reduce cholesterol, prevent cardiovascular disease, and are among the most
commonly prescribed medications in the world. Statin‐associated musculoskeletal symptoms (…

Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene

…, EJ Carlson, I Herskowitz, KM Giacomini… - Pharmacogenetics …, 2003 - journals.lww.com
Objectives There is increasing evidence that polymorphism of the ABCB1 (MDR1) gene
contributes to interindividual variability in bioavailability and tissue distribution of P-glycoprotein …

Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges

…, D Flockhart, I Zineh, KM Giacomini… - Nature reviews Drug …, 2007 - nature.com
Serious adverse drug reactions (SADRs) are a major cause of morbidity and mortality
worldwide. Some SADRs may be predictable, based upon a drug's pharmacodynamic and …